Evidence map›Paper›PMID 34289815›Full record

Observational studyBMC pulmonary medicine2021

Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk.

Chi-Tai Lee, Ping-Huai Wang

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04885933 (The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04885933 completednot on this map

The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk

Typeobservational_patient_registrySponsorFar Eastern Memorial HospitalRan2018 to 2020Enrolled43ConditionsSarcopenia, COPD ExacerbationArmssarcopenia measurement
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chi-Tai LeeDivision of Pulmonology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, 220, Taiwan, ROC.
Ping-Huai WangDivision of Pulmonology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, 220, Taiwan, ROC. pinghuaiwang@gmail.com.
Far Eastern Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow handgrip strength (HGS) is independently associated with a higher exacerbation risk in stable chronic obstructive pulmonary disease (COPD); however, the relationship between HGS while being admitted for COPD exacerbation and further exacerbation risk after discharge remains unclear.

methodsWe enrolled patients admitted for COPD exacerbation between January 2018 and June 2019. HGS tests were done within 3 days after admission. The primary endpoint was exacerbations within 12 months after the index admission, which needed emergency room visits or hospital admission. We analyzed the relationships among demographics, HGS, pulmonary function parameters, and acute exacerbation events.

resultsAmong 43 enrolled patients, 31 (72.1%) participants (HGSw) had HGS weakness (22.1 ± 4.1 kg). The other 12 (27.9%) participants (non-HGSw) had the strength of handgrips 33.7 ± 3.1 kg. HGSw group showed a significantly higher rate of emergency room visits within 6, 9, and 12 months after the index admission than non-HGSw group (0.81 ± 1.30 vs. 0.08 ± 0.29, p = 0.045; 1.26 ± 1.59 vs. 0.17 ± 0.38, P = 0.019; 1.48 ± 1.86 vs. 0.25 ± 0.62, P = 0.027, respectively). There was a trend to have higher admission rate within 9 and 12 months in HGSw group, which did not achieve statistical significance (0.77 ± 1.38 vs. 0.08 ± 0.29, P = 0.064; 0.94 ± 1.56 vs. 0.08 ± 0.29, P = 0.062, respectively).

conclusionsHGS weakness measured upon admission for COPD exacerbation was associated with a higher risk of exacerbation in the next year. Trial registration ClinicalTrials.gov Identifier: NCT04885933.

Indexed as

AgedAged, 80 and overDisease ProgressionFemaleForced Expiratory VolumeHand StrengthHospitalizationHumansMaleMiddle AgedMuscle StrengthMuscle WeaknessProportional Hazards ModelsProspective StudiesPulmonary Disease, Chronic ObstructiveTaiwanChronic obstructive pulmonary diseaseExacerbationHandgrip strength

Identifiers

PMID34289815
PMCPMC8296662
OpenAlexW3172748067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.